Metagenomic analysis of ocular surface microbiome in health and disease
Implementing Organization
Medical Research Foundation
Principal Investigator
Dr. Appakkudal R Anand
Chennai, Tamil Nadu
Medical Research Foundation
CO-Principal Investigator
Ms. Madhumathi Subramanian
Chettinad Health and Research Institute (CHRI), Chennai, Tamil Nadu 600006
Medical Research Foundation
CO-Principal Investigator
Dr. Geetha Iyer
Chettinad Health and Research Institute (CHRI), Chennai, Tamil Nadu 600006
Medical Research Foundation
CO-Principal Investigator
Dr. Rashima Asokan
Chettinad Health and Research Institute (CHRI), Chennai, Tamil Nadu 600006
Medical Research Foundation
CO-Principal Investigator
Dr. Dhanurekha Lakshmipathy
Chettinad Health and Research Institute (CHRI), Chennai, Tamil Nadu 600006
Medical Research Foundation
CO-Principal Investigator
Dr. Shweta S Agarwal
Chettinad Health and Research Institute (CHRI), Chennai, Tamil Nadu 600006
Medical Research Foundation
About
Ocular microbiota plays a crucial role in maintaining ocular surface homeostasis. However, there is limited knowledge about the composition and role of microbiota present on the ocular surface. Next-generation sequencing methods (NGS), particularly 16S rRNA gene-based NGS, have allowed for unprecedented analysis of microbiomes in various ecosystems. Recent studies have shown that changes in microbiota on a healthy ocular surface may predispose the eye to disease. Microbial dysbiosis has also been demonstrated in some types of ocular surface disease. However, most studies have been conducted in small cohorts, making interpretation difficult. The study aims to characterize the ocular surface microbiome in healthy subjects and in healthy subjects in the presence of external factors like contact lens and air pollution. It will also determine the ocular surface microbiome in dry eye disease, focusing on Meibomian gland dysfunction, Sjogren's syndrome, and Stevens-Johnson syndrome, compared to healthy controls. The data obtained will provide a better understanding of the role of bacterial communities in ocular health and disease, potentially leading to novel treatment modalities.
Source
Source
Anusandhan National Research Foundation/Science and Engineering Research Board (SERB), DST 2023-24
Science and Engineering Research Board (SERB), New Delhi
Anusandhan National Research Foundation (ANRF)
Quick Information
Area of Research
Life Sciences & Biotechnology
Start Year
2023
End Year
2026
Sanction Amount
₹ 43.22 L
Status
Ongoing
Contact
aranand@gmail.com
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
00
No. of Patents
Filed :00
Grant :00
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.